Of interest, siRNA targeting NOS2 blocked the increase in SOX2, Notch-2 and β-catenin expression in irradiated U87 glioma cells, thus inhibiting the stemness machinery for malignant progression. This evidence concerns the gene NOS2 and central nervous system cancer.